8-KThe WireStrategic
Agreement Terminated · Company Update
Filed Jun 27, 2024 · 2y ago · Accession 0001104659-24-075722
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- NRX Pharmaceuticals, Inc.
- Ticker
- NRXP
- CIK
- 1719406
- Form type
- 8-K
- Filing date
- Jun 27, 2024
- Report date
- Jun 21, 2024
- Document
- tm2418373d1_8k.htm
- Size
- 249 KB